Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins

被引:233
|
作者
Nappo, F
De Rosa, N
Marfella, R
De Lucia, D
Ingrosso, D
Perna, AF
Farzati, B
Giugliano, D
机构
[1] Univ Naples 2, Dept Geriatr & Metab Dis, Naples, Italy
[2] Univ Naples 2, Dept Immunol, Naples, Italy
[3] Univ Naples 2, Inst Gen Pathol & Oncol, Naples, Italy
[4] Univ Naples 2, Inst Biochem Macromol, Naples, Italy
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1999年 / 281卷 / 22期
关键词
D O I
10.1001/jama.281.22.2113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context. Increased levels of homocysteine are associated with risk of cardiovascular disease. Homocysteine may cause this risk by impairing endothelial cell function. Objective. To evaluate the effect of acute hyperhomocysteinemia with and without antioxidant vitamin pretreatment on cardiovascular risk factors and endothelial functions. Design and Setting. Observer-blinded, randomized crossover study conducted at a university hospital in Italy. Subjects. Twenty healthy hospital staff volunteers (10 men, 10 women) aged 25 to 45 years. Interventions. Subjects were given each of 3 loads in random order at 1-week intervals: oral methionine, 100 mg/kg in fruit juice; the same methionine load immediately following ingestion of antioxidant vitamin E, 800 IU, and ascorbic acid, 1000 mg; and methionine-free fruit juice (placebo). Ten of the 20 subjects also ingested a placebo load with vitamins. Main Outcome Measures. Lipid, coagulation, glucose, and circulating adhesion molecule parameters, blood pressure, and endothelial functions as assessed by hemodynamic and theologic responses to L-arginine, evaluated at baseline and 4 hours following ingestion of the loads. Results. The oral methionine load increased mean (SD) plasma homocysteine level from 10.5 (3.8) mu mol/L at baseline to 27.1 (6.7) mu mol/L at 4 hours (P < .001). A similar increase was observed with the same load plus vitamins (10.0 [4.0] to 22.7 [7.8] mu mol/L; P < .001) but no significant increase was observed with placebo (10.1 [3.7] to 10.4 [3.2] mu mol/L; P = .75). Coagulation and circulating adhesion molecule levels significantly increased after methionine ingestion alone (P < .05) but not after placebo or methionine ingestion with vitamins. While the mean (SD) blood pressure (-7.0% [2.7%]; P < .001), platelet aggregation response to adenosine diphosphate (-11.4% [4.5%]; P = .009) and blood viscosity (-3.0% [1.2%]; P = .04) declined in these parameters 10 minutes after an L-arginine load (3 g) following placebo, the increase after methionine alone (-2.3% [1.5%], 4.0% [3.0%], and 1.5% [1.0%], respectively; P < .05), did not occur following methionine load with vitamin pretreatment (-6.3% [2.5%], -7.9% [3.5%], and -1.5% [1.0%], respectively; P = .24). Conclusion. Our data suggest that mild to moderate elevations of plasma homocysteine levels in healthy subjects activate coagulation, modify the adhesive proper ties of endothelium, and impair the vascular responses to L-arginine. Pretreatment with antioxidant vitamin E and ascorbic acid blocks the effects of hyperhomocysteinemia, suggesting an oxidative mechanism.
引用
收藏
页码:2113 / 2118
页数:6
相关论文
共 50 条
  • [31] The Protection Potential of Antioxidant Vitamins Against Acute Respiratory Distress Syndrome: a Rat Trial
    Nazli Erol
    Leyla Saglam
    Yavuz Selim Saglam
    Huseyin Serkan Erol
    Serdar Altun
    Mustafa Sinan Aktas
    Mesut Bunyami Halici
    Inflammation, 2019, 42 : 1585 - 1594
  • [32] Antioxidant vitamins C and E ameliorate hyperglycaemia-induced oxidative stress in coronary endothelial cells
    Ülker, S
    McMaster, D
    McKeown, PP
    Bayraktutan, U
    DIABETES OBESITY & METABOLISM, 2004, 6 (06): : 442 - 451
  • [33] Effects of Antioxidant Components of AREDS Vitamins and Zinc Ions on Endothelial Cell Activation: Implications for Macular Degeneration
    Zeng, Shemin
    Hernandez, Jasmine
    Mullins, Robert F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (02) : 1041 - 1047
  • [34] Methionine-Induced Homocysteinemia Impairs Endothelial Function in Hypertensives: The Role of Asymmetrical Dimethylarginine and Antioxidant Vitamins
    Tousoulis, Dimitris
    Bouras, George
    Antoniades, Charalambos
    Marinou, Kyriakoula
    Papageorgiou, Nikolaos
    Miliou, Antigoni
    Hatzis, George
    Stefanadi, Elli
    Tsioufis, Costas
    Stefanadis, Christodoulos
    AMERICAN JOURNAL OF HYPERTENSION, 2011, 24 (08) : 936 - 942
  • [35] Methionine-induced homocysteinemia impairs endothelial function in hypertensives: the role of asymmetrical dimethylarginine and antioxidant vitamins
    Bouras, G.
    Tousoulis, D.
    Antoniades, C.
    Marinou, K.
    Papageorgiou, N.
    Miliou, A.
    Hatzis, G.
    Stefanadi, E.
    Tentolouris, C.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2011, 32 : 585 - 586
  • [36] Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia - Endothelial assessment of risk from lipids in youth (EARLY) trial
    Engler, MM
    Engler, MB
    Malloy, MJ
    Chiu, EY
    Schloetter, MC
    Paul, SM
    Stuehlinger, M
    Lin, KY
    Cooke, JP
    Morrow, JD
    Ridker, PM
    Rifai, N
    Miller, E
    Witztum, JL
    Mietus-, M
    CIRCULATION, 2003, 108 (09) : 1059 - 1063
  • [37] IMPAIRMENT OF MEMORY FUNCTIONS AFTER ACUTE HEAD-INJURY
    FODOR, IE
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1972, 35 (06): : 818 - 824
  • [38] Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia
    Tam, LS
    Fan, BL
    Li, EK
    Thomas, GN
    Yim, SF
    Haines, CJ
    Tomlinson, B
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (07) : 1479 - 1484
  • [39] Antioxidant vitamins up-regulate prostaglandin E(2) receptor functions in oral mucosa.
    WuWang, CY
    Xu, XR
    Mahamadeen, F
    Wang, SL
    FASEB JOURNAL, 1997, 11 (03): : 2991 - 2991
  • [40] DO ANTIOXIDANT VITAMINS REDUCE INFARCT SIZE FOLLOWING ACUTE MYOCARDIAL-ISCHEMIA REPERFUSION
    BELLOWS, SD
    HALE, SL
    SIMKHOVICH, BZ
    KAY, GL
    KLONER, RA
    CARDIOVASCULAR DRUGS AND THERAPY, 1995, 9 (01) : 117 - 123